SLE is a chronic autoimmune rheumatic disorder of high heterogeneity in clinical
presentation, treatment response and prognosis. Long-term outcomes in SLE have been …

Background Sporadic studies suggest hydroxychloroquine (HCQ) may be effective for
thrombosis prevention in patients with primary antiphospholipid syndrome (PAPS) and may …

The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
morbidity in the presence of antiphospholipid antibodies, including anti-β2-glycoprotein-I …

The renaissance of complement diagnostics and therapeutics has introduced precision
medicine into a widened field of complement-mediated diseases. In particular, complement …

Thrombocytopenia during pregnancy presents unique challenges for the hematologist.
Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
recurrent venous or arterial thrombosis with or without pregnancy morbidity in the presence …

Despite its potential to cause significant morbidity in children, pediatric antiphospholipid
syndrome (APS) is an understudied condition. In this review, we will cover what is known …

The antiphospholipid syndrome (APS) was fully recognized as a clinical entity in the early
1980s. Still, more than 30 years later, the epidemiology of APS is not well described, and …

Abstract Purpose of the Review To review the available evidence on the management of a
variety of non-criteria manifestations in antiphospholipid syndrome (APS), including valvular …

Objective To assess childhood-onset systemic lupus erythematosus-related
antiphospholipid syndrome (cSLE-APS) in a large Brazilian population. Methods A …